Radionuclide treatment of painful bone metastases in patients with breast cancer: A systematic review

Cancer Treatment Reviews

Volumn 38, Issue 2, 2012, Pages 164-171

  Christensen, Mette H ^a   Petersen, Lars J ^a,b  

^a VIBORG HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Bone metastasis; Breast cancer; Pain; Radionuclides; Rhenium 186; Samarium 153; Strontium 89

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; RADIOISOTOPE; RHENIUM 186; SAMARIUM 153; STRONTIUM 89;

BLOOD TOXICITY; BONE METASTASIS; BONE PAIN; BREAST METASTASIS; CANCER PAIN; CANCER PATIENT; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; HUMAN; LEUKOPENIA; QUALITY OF LIFE; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 84856343083     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2011.05.008     Document Type: Review

References (30)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Morrison L.J., Morrison R.S. Palliative care and pain management. Med Clin North Am 2006, 90:983-1004.
3. Roque M., Martinez M.J., Alonso P., et al. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev 2003, CD003347.
4. Bauman G., Charette M., Reid R., Sathya J. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother Oncol 2005, 75:258-270.
5. Paes F.M., Serafini A.N. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Semin Nucl Med 2010, 40:89-104.
6. Han S.H., de Klerk J.M., Tan S., et al. The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo controlled Rhenium study. J Nucl Med 2002, 43:1150-1156.
7. Sartor O., Reid R.H., Hoskin P.J., et al. Samarium-153-lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology 2004, 63:940-945.
8. Sartor O., Reid R.H., Bushnell D.L., Quick D.P., Ell P.J. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain. Cancer 2007, 109:637-643.
9. Lewington V.J., McEwan A.J., Ackery D.M., et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991, 27:954-958.
10. Dafermou A., Colamussi P., Giganti M., et al. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med 2001, 28:788-798.
11. Francesca F., Bader P., Echtle D., Giunta F., Williams J. EAU guidelines on pain management. Eur Urol 2003, 44:383-389.
12. Horwich A., Parker C., Kataja V. Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl. 4):76-78.
13. Mohler J., Bahnson R.R., Boston B., et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010, 8:162-200.
14. Bodei L., Lam M., Chiesa C., et al. EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging 2008, 35:1934-1940.
15. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
16. Liu S.S., Togioka B.M., Hurley R.W., et al. Methodological quality of randomized controlled trials of postoperative epidural analgesia: validation of the epidural analgesia trial checklist as a specific instrument to evaluate methodology. Reg Anesth Pain Med 2010, 35:549-555.
17. Moher D., Hopewell S., CONSORT Schulz.K.F., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869.
18. Petersen L.J., Kristensen J.K. Selection of patients to psoriasis clinical trials: a survey of the dermatological literature. J Dermatol Treat 1992, 3:171-176.
19. Kucuk N.O., Ibis E., Aras G., et al. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Ann Nucl Med 2000, 14:239-245.
20. Baczyk M., Czepczynski R., Milecki P., et al. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Nucl Med Commun 2007, 28:245-250.
21. Sciuto R., Festa A., Pasqualoni R., et al. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast Cancer Res Treat 2001, 66:101-109.
22. Resche I., Chatal J.F., Pecking A., et al. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997, 33:1583-1591.
23. Finlay I.G., Mason M.D., Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol 2005, 6:392-400.
24. Serafini A.N. Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease. Int J Radiat Oncol Biol Phys 1994, 30:1187-1194.
25. Pandit-Taskar N., Batraki M., Divgi C.R. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 2004, 45:1358-1365.
26. Nilsson S., Franzen L., Parker C., et al. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. Lancet Oncol 2007, 8:587-594.
27. Porter A.T., McEwan A.J., Powe J.E., et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1993, 25:805-813.
28. Logothetis C.J., Lin S.H. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 2005, 5:21-28.
29. Logothetis C.J., Navone N.M., Lin S.H. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer. Clin Cancer Res 2008, 14:1599-1602.
30. Lipton A., Uzzo R., Amato R.J., et al. The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Canc Netw 2009, 7(Suppl. 7):S1-S29.